Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.33B | 10.31B | 10.12B | 9.97B | 10.35B | 10.11B |
Gross Profit | 4.72B | 4.61B | 4.76B | 4.93B | 5.15B | 4.93B |
EBITDA | 812.83M | 1.20B | 1.35B | 1.71B | 2.08B | 1.90B |
Net Income | 266.07M | 229.98M | 346.68M | 575.59M | 809.00M | 666.86M |
Balance Sheet | ||||||
Total Assets | 12.68B | 12.42B | 12.42B | 12.28B | 12.18B | 11.84B |
Cash, Cash Equivalents and Short-Term Investments | 4.16B | 4.45B | 4.13B | 4.26B | 4.32B | 3.64B |
Total Debt | 3.52B | 3.35B | 3.39B | 3.35B | 3.48B | 3.73B |
Total Liabilities | 5.53B | 5.20B | 5.29B | 5.23B | 5.57B | 5.91B |
Stockholders Equity | 7.15B | 7.23B | 7.13B | 7.05B | 6.61B | 5.93B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.06B | 822.11M | 692.91M | 1.38B | 1.26B |
Operating Cash Flow | 0.00 | 1.18B | 849.59M | 710.68M | 1.42B | 1.35B |
Investing Cash Flow | 0.00 | -132.34M | 6.90M | -86.26M | -35.76M | -96.42M |
Financing Cash Flow | 0.00 | -723.14M | -991.10M | -685.55M | -701.76M | -856.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥6.58B | 7.05 | 2.37% | 7.72% | 72.38% | ||
77 Outperform | ¥14.03B | 19.84 | 3.00% | 11.76% | 9.90% | ||
72 Outperform | ¥3.51B | 13.11 | 3.71% | 13.49% | 17.08% | ||
69 Neutral | ¥32.67B | 10.08 | 2.69% | 5.01% | -39.78% | ||
67 Neutral | ¥3.18B | 12.44 | 5.28% | 1.87% | -33.27% | ||
65 Neutral | ¥8.81B | 56.40 | ― | 13.52% | -45.02% | ||
65 Neutral | $10.65B | 15.52 | 5.51% | 1.92% | 2.72% | -26.34% |